Biogen (BIIB) Stock Price
$118.6 2.9%
to add to portfolio
AI Score
-
Alternative
4 -
Fundamental
4 -
Technical
2
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Biogen, AI stock picks, stock alerts and much more.
BIIB AI Stock Analysis
AI stock analysis for BIIB is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Biogen (BIIB) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Biogen (BIIB) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Biogen (BIIB), currently trading at $118.6, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About BIIB
-
Biogen Inc.
-
Symbol
BIIB
-
Market
NASDAQ
-
Industry
Drug Manufacturers - General
-
Market Cap
17.4B
Similar Stocks
 |
Astrazeneca AZN |
$67.59 0.8% |
6 |
 |
Amgen AMGN |
$277.3 1.9% |
5 |
 |
Gilead Sciences GILD |
$104.5 0.3% |
6 |
 |
Sanofi SNY |
$50.9 0.7% |
5 |
News
BIIB Alternative Data
Web Traffic
Biogen receives an estimated 138838 monthly visitors to biogen.com.
-
Web Traffic
138838
-
Change from Previous Month
16.6%
-
3 Month Change
27.3%
-
YoY Change
27.3%
News Mentions
Biogen was mentioned 8 times in the news yesterday.
-
News Mentions
8
-
Daily Change
100%
-
1 Month Change
166.7%
-
3 Month Change
166.7%
Reddit Mentions
Biogen has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
Twitter Followers
Biogen has 45,076 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.2% over the last month.
-
Twitter Followers
45076
-
Daily Change
0%
-
1 Month Change
0.2%
-
3 Month Change
0.8%
-
YoY Change
0.8%
Facebook Engagement
Biogen has engaged 51 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
51
-
Daily Change
15%
-
1 Month Change
94.1%
-
3 Month Change
86.1%
-
YoY Change
86.1%
Youtube Subscribers
Biogen has 10,200 subscribers on its main Youtube channel, up by 1% over the last month.
-
Youtube Subscribers
10200
-
Daily Change
0%
-
1 Month Change
1%
-
3 Month Change
2.8%
-
YoY Change
2.8%
LinkedIn Followers
1,102,924 are following Biogen on LinkedIn, up by 1.4% over the last month.
-
LinkedIn Followers
1102924
-
Daily Change
0.1%
-
1 Month Change
1.4%
-
3 Month Change
3.7%
Job Postings
Biogen currenly has an estimated 177 open job postings, up by 4.1% over the last month.
-
Job Postings
177
-
Daily Change
0%
-
1 Month Change
4.1%
-
3 Month Change
10.6%
-
YoY Change
10.6%
LinkedIn Employees
According to LinkedIn, Biogen has 7,749 employees, up by 0% over the last month.
-
LinkedIn Employees
7749
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0.9%
-
YoY Change
0.9%
Business Outlook
According to employee reviews, the business outlook among employees at Biogen is 40 out of 100 (bearish).
-
Business Outlook
40
-
Change from Previous Month
4.8%
-
3 Month Change
0%
-
YoY Change
0%
BIIB Financials
BIIB Key Metrics
-
Total Revenue
$2.5B
-
Net Income
$266.8M
-
Earnings per Share
$1.83
-
Free cash flow
$800.2M
-
EBITDA
$0
-
EBITDA Ratio
0
-
Total Assets
$28B
BIIB 2-year Revenue & Income
BIIB 2-year Free Cash Flow
BIIB Technicals
BIIB SMA
BIIB RSI
FAQ
What's the current price of Biogen (BIIB) Stock?
The price of an Biogen (BIIB) share is $118.6.
What's the market cap of Biogen?
The current market cap of Biogen is 17.4B.
Should I buy or sell BIIB?
Biogen exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.
Is Biogen a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Biogen stock. There are several bearish signals and market challenges that could negatively impact Biogen's future performance, suggesting that caution should be exercised before making any investment decisions.
Is now a good time to buy Biogen (BIIB) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Biogen stock right now, as the outlook appears bearish.
What are some stocks similar to Biogen (BIIB) that investors often compare it to?
Biogen (BIIB) is often compared to similar stocks such as Astrazeneca, Amgen, Gilead Sciences and Sanofi.
What is the forecast for Biogen's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Biogen's stock price to be around $111.3 in 2026. Starting from the current price of $118.6, this represents a 6.1% change in price, indicating a bearish outlook for the stock.
How to buy Biogen (BIIB) Stock?
Biogen stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Biogen shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.